About
Research
Patient Care
Education
Community
Mar 15, 2023
UCI Anti-Cancer Challenge returns on Oct. 7 to raise funds for life-saving research
On Saturday, Oct. 7, 2023, UCI Anti-Cancer Challenge participants and supporters will gather at UCI Aldrich Park to enjoy festivities dedicated to raising funds and awareness for critical cancer research. Individuals who register to ride, run, walk or volunteer can get involved in person or virtually.
Aug 10, 2022 | UCI School of Medicine
New UCI-led research reveals the circadian clock influences cell growth, metabolism and tumor progression
In a new University of California, Irvine-led study, researchers define how the circadian clock influences cell growth, metabolism and tumor progression. Their research also reveals how disruption of the circadian clock impacts genome stability and mutations that can further drive critical tumor promoting pathways in the intestine.
New UCI-led study reveals computation-guided approach to suppressing cancer tumor growth
A new study, led by researchers from the University of California, Irvine and the University of California, San Diego, reveals a new computation-guided approach to identify small molecules that can restore aspects of wild-type p53 tumor suppression function to mutated p53, which play an important role in many human cancers. This approach was successful both in vitro and in vivo. This strategy can increase chemical diversity of p53 corrector molecules for clinical development.
Anne Warde Director, Communications and Public Relations 949-824-6357 awarde@hs.uci.edu
Michelle Strombeck Manager, Communications and Public Relations 949-824-9024 mstrombe@hs.uci.edu
A pilot intervention is helping Latinx families care for their children with cancer. Corazones Unidos Por Una Vida (Hearts United for Life) is a prototype program of support for Latinx families with children who are undergoing cancer treatment at Children’s Hospital of Orange County. It is designed and driven by Associate Professor Michelle Fortier, a clinical psychologist and pediatric pain expert at the Sue & Bill Gross School of Nursing and UCI Center on Stress and Health. Fortier is also a CFCCC member.
Professor of population health and disease prevention and general internal medicine – Lari Wenzel, PhD, from the UCI Program in Public Health and the School of Medicine, is retiring at the end of June after 27 years of campus service. She leaves an outstanding legacy of achievements and a portfolio of valuable cancer research. Her contributions to the public health field are truly remarkable and her impact on countless students, faculty, and communities around the nation cannot be overstated.
Drs. Jacqueline Kim, Sunmin Lee, and Edward Kuan, Cancer Control Members, receive School of Medicine New Investigator Faculty Research Grant. The overall goal of this funding mechanism is to help early-stage investigators in the School of Medicine obtain extramural funding and to promote collaborative interdisciplinary research.
Mar 09, 2023
Kickass Women at UC Irvine - Dr. Sora Park Tanjasiri
After teaching at Cal State Fullerton for 15 years, Tanjasiri was recruited by the Chao Family Comprehensive Cancer Center, one of only 51 cancer centers nationwide funded by the National Cancer Institute. She’s spent her career focused on cancer research and prevention, particularly in communities of color who are at the greatest risk.
Jan 31, 2023
The Caris Precision Oncology Alliance Welcomes The UCI Health Chao Family Comprehensive Cancer Center
Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that the UCI Health Chao Family Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™ (POA). The POA is a growing network of leading cancer centers across the globe that collaborate to advance precision oncology and biomarker-driven research. POA members work together to establish and optimize standards of care for molecular testing through innovative research focused on predictive and prognostic markers that improve the clinical outcomes for cancer patients.